Research Paper Volume 15, Issue 18 pp 9779—9796
Pan-cancer analysis and experimental validation identify ndc1 as a potential immunological, prognostic and therapeutic biomarker in pancreatic cancer
Figure 1. (A) Flowchart. (B) Expression of NDC1 in pan-cancer based on TCGA and GTEx databases (yellow for tumor tissue and blue for normal tissue). (C) Expression of NDC1 in different cell lines from the CCLE database. (D) Relationship between NDC1 expression and tumor stage in ACC, BRCA, COAD and LIHC.